CO6220936A2 - 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas - Google Patents
5-oxoisoxazoles como inhibidores de lipasas y fosfolipasasInfo
- Publication number
- CO6220936A2 CO6220936A2 CO09107072A CO09107072A CO6220936A2 CO 6220936 A2 CO6220936 A2 CO 6220936A2 CO 09107072 A CO09107072 A CO 09107072A CO 09107072 A CO09107072 A CO 09107072A CO 6220936 A2 CO6220936 A2 CO 6220936A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- alkylene
- cycloalkyl
- aryl
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
Abstract
1.- Un compuesto de la fórmula Ien la que los significados son: R1 alquilo (C5-C16), Y-arilo, Y-heteroarilo, donde el arilo o heteroarilo puede estar sustituido una o más veces con F, CI, Br, I, OH, CF3, NO2, CN, OCF3, O-alquilo (C1-C6), O-alcoxi (C1-C4)-alquilo (C1-C4), S-alquilo (C1-C6), alquilo (C1-C6), haloalquilo (C2-C4), O-haloalquilo (C2-C4), alquenilo (C2-C6), cicloalquilo (C3-C8), O-cicloalquilo (C3-C8), alquinilo (C2-C6)-, alquileno (C0-C8)-arilo, O-alquileno (C0-C8)-arilo, S-arilo, alquileno (C0-C8)-heteroarilo, N(R4)(R5), SO2-CH3, SO2-NH2, SF5, COOH, COO-alquilo (C1-C6), CON(R6)(R7), N(R8)CO(R9), N(R10)SO2(R11), CO(R12), (CR13R14)x- O(R15), O-CO-N(R16)(R17), O-CO-alquileno (C1-C6)-CO-O-alquilo (C1-C6), O-CO-alquileno (C1-C6)-CO-OH, O-CO-alquileno (C1-C6)-CO-N(R18)(R19), donde el arilo o heteroarilo puede estar sustituido, a su vez, una o más veces con F, CI, Br, I, OH, CF3, NO2, CN, OCF3, O-alquilo (C1-C6), O-alcoxi (C1-C4)-alquilo (C1-C4), S-alquilo (C1-C6), alquilo (C1-C6), haloalquilo (C2-C4), alquenilo (C2-C6), cicloalquilo (C3-C8), O-cicloalquilo (C3-C8), alquinilo (C2-C6), N(R4a)(R5a), SO2-CH3, SF5, COOH, COO-alquilo (C1-C6), CON(R6a)(R7a), N(R8a)CO(R9a), N(R10a)SO2(R11a), CO(R12a), (CR13aR14a)x-O(R15a), O-CO-N(R16a)(R17a), O-CO-alquileno (C1-C6)-CO-O-alquilo (C1-C6), O-CO-alquileno (C1-C6)-CO-OH, O-CO-alquileno (C1-C6)-CO-N(R18a)(R19a); x, x' 0, 1, 2, 3, 4, 5, 6; R4, R5, R6, R7, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R4a, R5a, R6a, R7a, R9a, R10a, R11a, R12a, R13a, R14a, R15a, R16a, R17a, R18a, R19a independientemente entre sí hidrógeno o alquilo (C1-C8); o un radical de la fórmula la con W -C(R26)(R27)-, -C(R26)(R27)-(R28)(R29)-, -C(R26)(R27)-O-R20, R21, R22, R23, R24, R25, R26, R27, R28, R29 son iguales o diferentes y son hidrógeno, F, CI, Br, I, OH, CF3, NO2, CN, OCF3, SF5, O-alquilo (C1-C6), O-alcoxi (C1-C4)-alquilo (C1-C4), S-alquilo (C1-C6), alquilo (C1-C6), haloalquilo (C2-C4), O-haloalquilo (C2-C4), alquenilo (C2-C6), cicloalquilo (C3-C8), O-cicloalquilo (C3-C8), ...
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07007251 | 2007-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6220936A2 true CO6220936A2 (es) | 2010-11-19 |
Family
ID=38458105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09107072A CO6220936A2 (es) | 2007-04-05 | 2009-09-30 | 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas |
Country Status (19)
Country | Link |
---|---|
US (1) | US9029400B2 (es) |
EP (1) | EP2144891B1 (es) |
JP (1) | JP2010523504A (es) |
KR (1) | KR20090127418A (es) |
CN (1) | CN101657435A (es) |
AR (1) | AR065934A1 (es) |
AU (1) | AU2008235071A1 (es) |
BR (1) | BRPI0810044A2 (es) |
CA (1) | CA2682891A1 (es) |
CL (1) | CL2008000982A1 (es) |
CO (1) | CO6220936A2 (es) |
IL (1) | IL201254A0 (es) |
MA (1) | MA31295B1 (es) |
MX (1) | MX2009010483A (es) |
RU (1) | RU2009140760A (es) |
TW (1) | TW200911765A (es) |
UY (1) | UY31000A1 (es) |
WO (1) | WO2008122357A1 (es) |
ZA (1) | ZA200906212B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19960917A1 (de) | 1999-12-17 | 2001-06-21 | Bayer Ag | Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen |
WO2004093872A1 (en) | 2003-03-31 | 2004-11-04 | Eli Lilly And Company | 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
WO2004094394A1 (en) | 2003-04-01 | 2004-11-04 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
US7217727B2 (en) * | 2003-04-01 | 2007-05-15 | Eli Lilly And Company | Phospholipase inhibitors |
DE102004005172A1 (de) * | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
DE102005018389A1 (de) | 2005-04-20 | 2006-10-26 | Sanofi-Aventis Deutschland Gmbh | Azolderivate als Inhibitoren von Lipasen und Phospholipasen |
-
2008
- 2008-03-22 CA CA002682891A patent/CA2682891A1/en not_active Abandoned
- 2008-03-22 JP JP2010501403A patent/JP2010523504A/ja not_active Withdrawn
- 2008-03-22 MX MX2009010483A patent/MX2009010483A/es unknown
- 2008-03-22 KR KR1020097020724A patent/KR20090127418A/ko not_active Application Discontinuation
- 2008-03-22 AU AU2008235071A patent/AU2008235071A1/en not_active Abandoned
- 2008-03-22 WO PCT/EP2008/002314 patent/WO2008122357A1/de active Application Filing
- 2008-03-22 RU RU2009140760/04A patent/RU2009140760A/ru not_active Application Discontinuation
- 2008-03-22 EP EP08716677.3A patent/EP2144891B1/de active Active
- 2008-03-22 CN CN200880010963A patent/CN101657435A/zh active Pending
- 2008-03-22 BR BRPI0810044-6A2A patent/BRPI0810044A2/pt not_active Application Discontinuation
- 2008-04-02 TW TW097111928A patent/TW200911765A/zh unknown
- 2008-04-03 AR ARP080101391A patent/AR065934A1/es unknown
- 2008-04-03 UY UY31000A patent/UY31000A1/es not_active Application Discontinuation
- 2008-04-04 CL CL200800982A patent/CL2008000982A1/es unknown
-
2009
- 2009-09-08 ZA ZA200906212A patent/ZA200906212B/xx unknown
- 2009-09-30 IL IL201254A patent/IL201254A0/en unknown
- 2009-09-30 CO CO09107072A patent/CO6220936A2/es not_active Application Discontinuation
- 2009-10-02 MA MA32250A patent/MA31295B1/fr unknown
- 2009-10-05 US US12/573,335 patent/US9029400B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TW200911765A (en) | 2009-03-16 |
CA2682891A1 (en) | 2008-10-16 |
MX2009010483A (es) | 2009-10-19 |
ZA200906212B (en) | 2010-05-26 |
JP2010523504A (ja) | 2010-07-15 |
BRPI0810044A2 (pt) | 2014-10-14 |
EP2144891A1 (de) | 2010-01-20 |
CL2008000982A1 (es) | 2008-10-10 |
CN101657435A (zh) | 2010-02-24 |
AU2008235071A1 (en) | 2008-10-16 |
KR20090127418A (ko) | 2009-12-11 |
US9029400B2 (en) | 2015-05-12 |
US20100152246A1 (en) | 2010-06-17 |
AR065934A1 (es) | 2009-07-15 |
WO2008122357A1 (de) | 2008-10-16 |
EP2144891B1 (de) | 2016-06-15 |
IL201254A0 (en) | 2010-05-31 |
MA31295B1 (fr) | 2010-04-01 |
RU2009140760A (ru) | 2011-05-10 |
UY31000A1 (es) | 2008-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6220936A2 (es) | 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas | |
PE20050431A1 (es) | Peptidos macrociclicos activos contra el virus de la hepatitis c | |
CR11223A (es) | Compuestos de biciclolactama sustituida | |
AR054621A1 (es) | 1-aril-4-ciclopropilpirazoles sustituidos | |
DK1877463T3 (da) | Polyesterpolyoler indeholdende sekundære alkoholgrupper og deres anvendelse ved fremstilling af polyurethaner, såsom fleksible polyurethanskum | |
AR051985A1 (es) | Derivados de quinazolina inhibidores de quinasas dirigidos a multiples blancos | |
ATE505243T1 (de) | Spielsteuerungsgehäuse, spielsteuerungsgehäusesatz und soundausgabesteuerungssystem | |
CO6220934A2 (es) | Derivados de imidazolidinacaboxamida como inhibidores de lipasas y foffolipasas | |
AR053994A1 (es) | Sulfonilpirrolidinas sustituidas procedimiento para su preparacion y su uso como medicamentos | |
CO6241157A2 (es) | "derivados de 6-(pirrolidin-3-il)-1h-pirazolo{3,4-d}pirimidin-4(5h)-ona utiles como inhibidores de pde9" | |
PE20010113A1 (es) | Derivados de piperidina utiles como antagonistas ccr5 | |
AR064635A1 (es) | Derivados de benzotiazolona | |
DOP2010000065A (es) | Mejoras en compuesto organicos o relacionadas con los mismos | |
PE20070409A1 (es) | Mezclas fungicidas con base en bifenilamidas de acido pirazolcarboxilico disustituidas en 2,4 | |
EP1857487A4 (en) | POLYMER OF AN ALIPHATIC KETONE | |
MY163155A (en) | Inter-organ spacer for use in endoscopic surgery | |
EA200401217A1 (ru) | ИЗОСТРУКТУРНЫЕ ПСЕВДОПОЛИМОРФЫ 9-ДЕЗОКСО-9a-АЗА-9a-МЕТИЛ-9a-ГОМОЭРИТРОМИЦИНА A | |
AR062131A1 (es) | Profarmacos antimicrobianos de oxazolidinona | |
ECSP056141A (es) | 3-carbonilaminotiofenos y su uso como fungicidas | |
AR085590A1 (es) | Eteres de oxima microbicidas | |
WO2007048586A3 (en) | Polymer and compositions | |
CO6270230A2 (es) | Estratrienos 8-beta-sustituidos como estrogenos de accion selectivos | |
Sanchez et al. | Varied Family-Oriented Games to Stimulate Motor Skills in Children in the Third Year of Life | |
Hess | " The Last Great Cause": The Spanish Civil War and Music of the Americas | |
Paz | Defining Manila through archaeology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |